This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages) |
Professor Didier Robert Pittet | |
---|---|
Director, Infection Control Programme, University Hospital of Geneva, Geneva, Switzerland | |
Assumed office 1 January 1992 | |
External Lead,World Health Organization (WHO) Global Patient Safety Challenge "Clean Care is Safer Care" and African Partnerships for Patient Safety | |
Assumed office 1 September 2004 | |
Personal details | |
Born | 20 March 1957 Geneva,Switzerland |
Residence(s) | Geneva,Switzerland |
Education | Collège Calvin |
Alma mater | University of Geneva Faculty of Medicine |
Profession | Physician |
Didier Pittet (born 20 March 1957 in Geneva,Switzerland) is an infectious diseases expert and the director of the Infection Control Programme and WHO Collaborating Centre on Patient Safety,University Hospital of Geneva,Geneva,Switzerland. Since 2005,Pittet is also the External Lead of the World Health Organization (WHO) Global Patient Safety Challenge "Clean Care is Safer Care" and African Partnerships for Patient Safety.
In the 2007 New Year Honours List,Didier Pittet was awarded the Honorary Commander of the Order of the British Empire [1] (CBE) in recognition of his services related to the prevention of healthcare-associated infections in the UK.
Pittet graduated in 1976 from the Collège Calvin secondary school in Geneva,Switzerland. Following a Diploma in Tropical Medicine and Community Health at the University of Geneva Faculty of Medicine,he graduated as M.D. in 1983 from the same institution,and received a master's degree (MS) in Epidemiology and Public Health from the University of Iowa, [2] [3] Iowa City,US,in 1992. Pittet began his career as an infectious diseases expert with a special interest in the intensive care setting and device-associated and yeast infections,but this rapidly expanded to include research in overall hospital epidemiology and infection prevention and control. In 1992,he was appointed as Director of the Infection Control Programme at the University Hospital of Geneva and named Professor of Medicine in 2000 by the University of Geneva Faculty of Medicine.
Pittet is Visiting Professor,Division of Investigative Science and School of Medicine,Imperial College London,London,UK; [4] Honorary Professor,1st Medical School of the Fu,Shanghai,China; [5] Honorary Professor,Faculty of Health and Social Sciences,The Hong Kong Polytechnic University,Hong Kong,SAR,China. [6] Since 2002,Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Planning Committee member Since 2011,Co-Chair,1st International Conference on Prevention and Infection Control (ICPIC)
Initial observation studies in Geneva by Pittet's team showed a low compliance with basic hand hygiene practices and a lack of awareness by healthcare workers that the main cause of cross-transmission of microorganisms is by hands. [7] Time constraint was identified as the major determinant for poor compliance. [8] The challenge was to facilitate hand hygiene for staff and to find an innovative idea to do so. Under Pittet's leadership,the team investigated concepts from the social sciences to help understand the determinants driving healthcare worker behaviour,which led to the creation of a multimodal strategy based on education,recognition of opportunities for hand hygiene,and feedback on performance where the key component was the introduction of alcohol-based hand rub at the point of care to replace handwashing at the sink ("system change"),thus bypassing the time constraint of the latter method. [9]
The first multimodal intervention ran from 1995 to 2000 at the University of Geneva Hospitals with a spectacular decrease of almost 50% in hospital-associated infections and methicillin-resistant Staphylococcus aureus (MRSA) transmission in parallel with a sustained improvement in compliance with hand hygiene. The methodology and results were published in The Lancet in 2000 and the strategy became known in as "The Geneva Hand Hygiene Model". [9] During 1995–1997,Pittet had applied the same multimodal concept to a prevention strategy targeted at vascular access care and showed that it can decrease these infections and substantially impact on the overall incidence of all intensive care unit-acquired infections. [10] Similarly,interventions to reduce urinary tract infections were successfully applied. [11] Pittet's team also proved the cost-effectiveness of their interventions and long-term sustainability. [12] [13] Pittet's vision is that to advance infection prevention and control strategies,it is essential to seek insight and innovation through other specialty fields,such as anthropology or sociology,or even engineering,computer science,mathematical modelling,and systems thinking.
In 2004,Pittet was approached by the WHO World Alliance of Patient Safety to lead the First Global Patient Safety Challenge under the banner "Clean Care is Safer Care". [14] [15] [16] The mandate was to galvanise global commitment to tackle health-care associated infection,which had been identified as a significant area of risk for patients in all United Nations Member States. [17] Hand hygiene was to be the cornerstone of the Challenge. As co-author of the United States Centers for Disease Control and Prevention (CDC) Guidelines for Hand Hygiene, [18] Pittet proposed that WHO Guidelines for Hand Hygiene in Health Care be developed under his leadership in consultation with other international experts. The final version of the Guidelines [19] was published in 2009. In 2008,the infection control programme of the University of Geneva Hospitals and Faculty of Medicine was designated as the first WHO Collaborating Centre for Patient Safety (Infection Control and Improving Practices) in Europe.
The "Geneva Hand Hygiene Model" was used as the basis for the recommended implementation strategy [20] for the global promotion of hand hygiene. As of December 2011,"Clean Care is Safer Care" has been endorsed by ministers of health in over 120 countries worldwide―representing a coverage of more than 90% of the world population. Forty-two countries/networks [21] have already started hand hygiene initiatives using the proposed strategy. Alcohol-based hand rub is promoted actively as the new standard of care,including in resource-poor countries. [22] [23] Pittet's team developed the "Five Moments" concept to explain to healthcare workers the critical moments when hand hygiene must be carried out [24] and this model is currently used worldwide. Save Lives:Clean Your Hands is the Challenge's annual campaign with almost 15,000 hospitals registered from more than 150 countries at the end of December 2011.
Between 1991 and 2011, Pittet and his collaborators made significant contributions to different research fields. Five key references have been selected for each of the following main research topics:
Pittet is author/co-author of approximately 500 publications, including 300 peer-reviewed publications [30] and 50 chapters in authoritative medical textbooks.
This article lacks ISBNs for the books listed.(February 2012) |
{{cite journal}}
: CS1 maint: DOI inactive as of December 2024 (link){{cite journal}}
: CS1 maint: DOI inactive as of December 2024 (link){{cite journal}}
: CS1 maint: numeric names: authors list (link)Hand washing, also known as hand hygiene, is the act of cleaning one's hands with soap or handwash and water to remove viruses/bacteria/microorganisms, dirt, grease, and other harmful or unwanted substances stuck to the hands. Drying of the washed hands is part of the process as wet and moist hands are more easily recontaminated. If soap and water are unavailable, hand sanitizer that is at least 60% (v/v) alcohol in water can be used as long as hands are not visibly excessively dirty or greasy. Hand hygiene is central to preventing the spread of infectious diseases in home and everyday life settings.
Gastroenteritis, also known as infectious diarrhea, is an inflammation of the gastrointestinal tract including the stomach and intestine. Symptoms may include diarrhea, vomiting, and abdominal pain. Fever, lack of energy, and dehydration may also occur. This typically lasts less than two weeks. Although it is not related to influenza, in the U.S. and U.K., it is sometimes called the "stomach flu".
A hospital-acquired infection, also known as a nosocomial infection, is an infection that is acquired in a hospital or other healthcare facility. To emphasize both hospital and nonhospital settings, it is sometimes instead called a healthcare-associated infection. Such an infection can be acquired in a hospital, nursing home, rehabilitation facility, outpatient clinic, diagnostic laboratory or other clinical settings. A number of dynamic processes can bring contamination into operating rooms and other areas within nosocomial settings. Infection is spread to the susceptible patient in the clinical setting by various means. Healthcare staff also spread infection, in addition to contaminated equipment, bed linens, or air droplets. The infection can originate from the outside environment, another infected patient, staff that may be infected, or in some cases, the source of the infection cannot be determined. In some cases the microorganism originates from the patient's own skin microbiota, becoming opportunistic after surgery or other procedures that compromise the protective skin barrier. Though the patient may have contracted the infection from their own skin, the infection is still considered nosocomial since it develops in the health care setting. The term nosocomial infection is used when there is a lack of evidence that the infection was present when the patient entered the healthcare setting, thus meaning it was acquired or became problematic post-admission.
Following infection with HIV-1, the rate of clinical disease progression varies between individuals. Factors such as host susceptibility, genetics and immune function, health care and co-infections as well as viral genetic variability may affect the rate of progression to the point of needing to take medication in order not to develop AIDS.
Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.
Noma is a rapidly-progressive and often-fatal gangrenous infection of the mouth and face. Noma usually begins as an ulcer on gums and rapidly spreads into the jawbone, cheek, and soft tissues of the face. This is followed by death of the facial tissues and fatal sepsis. Survivors are left with severe facial disfigurement often with impairments in breathing, swallowing, speaking and vision. In 2023 noma was added to the World Health Organization's list of neglected tropical diseases.
In epidemiology, case fatality rate (CFR) – or sometimes more accurately case-fatality risk – is the proportion of people who have been diagnosed with a certain disease and end up dying of it. Unlike a disease's mortality rate, the CFR does not take into account the time period between disease onset and death. A CFR is generally expressed as a percentage. It is a measure of disease lethality, and thus may change with different treatments. CFRs are most often used for with discrete, limited-time courses, such as acute infections.
Hand sanitizer is a liquid, gel, or foam used to kill viruses, bacteria, and other microorganisms on the hands. It can also come in the form of a cream, spray, or wipe. While hand washing with soap and water is generally preferred, hand sanitizer is a convenient alternative in settings where soap and water are unavailable. However, it is less effective against certain pathogens like norovirus and Clostridioides difficile and cannot physically remove harmful chemicals. Improper use, such as wiping off sanitizer before it dries, can also reduce its effectiveness, and some sanitizers with low alcohol concentrations are less effective. Additionally, frequent use of hand sanitizer may disrupt the skin's microbiome and cause dermatitis.
Paratyphoid fever, also known simply as paratyphoid, is a bacterial infection caused by one of three types of Salmonella enterica. Symptoms usually begin 6–30 days after exposure and are the same as those of typhoid fever. Often, a gradual onset of a high fever occurs over several days. Weakness, loss of appetite, and headaches also commonly occur. Some people develop a skin rash with rose-colored spots. Without treatment, symptoms may last weeks or months. Other people may carry the bacteria without being affected; however, they are still able to spread the disease to others. Typhoid and paratyphoid are of similar severity. Paratyphoid and typhoid fever are types of enteric fever.
A virucide is any physical or chemical agent that deactivates or destroys viruses. The substances are not only virucidal but can be also bactericidal, fungicidal, sporicidal or tuberculocidal.
Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance
David M. Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently he is a Professor of Public Health at Makerere University School of Public Health, one of the schools of Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, the oldest university in Uganda. Serwadda is also a founding member of Accordia Global Health Foundation's Academic Alliance.
Sir Andrew Paul Haines, FMedSci is a British epidemiologist and academic. He was the Director of the London School of Hygiene & Tropical Medicine from 2001 to 2010.
Sir Alimuddin Zumla is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
Catherine S. Peckham is a British paediatrician.
The Milroy Lectures are given on topics in public health, to the Royal College of Physicians, London. They were set up by money left by Gavin Milroy, who died in 1886.
Oriol Mitjà i Villar is a Catalan-born Spanish researcher and consultant physician in internal medicine and infectious diseases with expertise in poverty-related tropical diseases. He has conducted research at the Lihir Medical Centre in Papua New Guinea since 2010 on new diagnostic and therapeutic tools to eradicate yaws. He was awarded the Princess of Girona Award in the scientific research category. Currently at the Germans Trias i Pujol Research Institute, Mitjà is conducting research on SARS-CoV-2 coronavirus disease (COVID-19) and strategies to control the infection at a community level.
Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.
Dale Andrew Fisher FRACP is an infectious diseases physician who specialises in Infectious Diseases and a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore, and the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore. In 2020, he became group chief of Medicine for National University Health Systems.